DL-CJCIPA-5
Research Blend
CJC-1295 / Ipamorelin Blend
This blend combines CJC-1295 with Drug Affinity Complex (DAC) and Ipamorelin in a single lyophilised vial. CJC-1295 is a modified GHRH analogue with covalent albumin-binding capability for extended half-life; Ipamorelin is a selective ghrelin receptor agonist. The combination is studied for potential synergistic stimulation of the GH/IGF-1 axis via complementary receptor pathways. Supplied with full analytical documentation; Certificate of Analysis available on request. For research use only.
Select Size
Bulk pricing — buy more, save more
3+ vials
5% off
5+ vials
10% off
10+ vials
15% off
Price
£31.99
Purity
≥99%
Formula
CJC-1295 (DAC): C154H256N44O44 � Ipamorelin: C38H49N9O5
Storage
-20°C
Form
Lyophilised Powder
Read the Ipamorelin & CJC-1295: A Research Overview for its class, mechanisms studied and laboratory handling.
Store at -20°C. Stable for 24 months lyophilised. For research use only. Not for human or veterinary use.
Molecular structure
- Formula
- CJC-1295 (DAC): C154H256N44O44 � Ipamorelin: C38H49N9O5
More Products
You may also like
Research Blend
GLOW
A regenerative research blend combining GHK-Cu (50mg), BPC-157 (10mg) and TB-500 (10mg) in a single 70mg vial.
From £54.99
Metabolic
Retatrutide
A novel triple agonist targeting GLP-1, GIP, and glucagon receptors, under investigation for metabolic and body composition research.
From £41.99
Metabolic
Tesamorelin
A synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification that significantly extends its half-life.
From £23.99
Customer reviews
No reviews yet — be the first to review CJC 1295/Ipamorelin.